| | |
| | | Substance or article in which exempted |
|
| Acetanilide; alkyl acetanilides |
| | | Substances not being preparations intended for the treatment of human ailments |
|
| | | Cosmetic products not intended for the treatment of human ailments |
|
| Alkaloids, the following: |
| | |
| | | Chinese proprietary medicines; herbal substances in raw form described in the current edition of “A Dictionary of Chinese Pharmacy” <<中药大辞典>> or “The Chinese Herbal Medicine Materia Medica” <<本草纲目>>, intended for the manufacture of Chinese proprietary medicines only |
|
| | | Surgical spirit containing not more than 0.015% of brucine; perfume containing not more than 0.015% of brucine |
|
| | | Ipecacuanha; extracts and tinctures of ipecacuanha; substances containing less than 0.05% of emetine |
|
| | | Substances containing less than 1% of the alkaloids of ephedra, except when contained in eye preparations |
|
| | | Substances containing less than 0.025% of the alkaloids of jaborandi; preparations containing not more than 2%, weight in weight, of the sulphate salt of trans‑pilosine |
|
| | | Preparations for the relief of asthma in the form of cigarettes, smoking mixtures or fumigants; substances containing less than 0.1% of the alkaloids of lobelia |
|
| | | Tobacco and tobacco products; preparations not intended for human consumption; other liquid preparations and solid preparations with a soap base, containing not more than 7.5% of nicotine, weight in weight |
|
| | Pomegranate, alkaloids of |
| | Pomegranate bark; cosmetic products not intended for the treatment of human ailments |
|
| | | Cosmetic products not intended for the treatment of human ailments |
|
| | | Tonic wines containing not more than 0.1% quinine calculated as base; aerated waters containing not more than 0.02% quinine calculated as base; other substances not being preparations for the treatment of human ailments; external preparations containing not more than 1% of quinine calculated as base |
|
| | | Stramonium contained in preparations for the relief of asthma in the form of cigarettes, smoking mixtures or fumigants; cosmetic products not intended for the treatment of human ailments |
|
| | | Soaps, ointments; lotions for external use |
|
| p-Aminobenzenesulphonamide; its salts; derivatives of p‑aminobenzenesulphonamide having any of the hydrogen atoms of the p-amino group or of sulphonamide group substituted by another radical; their salts |
| | | Feeding stuffs containing not more than 0.5% of total sulphonamides; sulphaquinoxaline when contained to a concentration not exceeding 0.5% in preparations for the destruction of rats and mice; solutions containing not more than 16% weight in volume of total sulphonamides for the treatment of diseases in animals; preparations containing sulfadoxine 500 mg used as an anti-malarial prophylactic in approved institution only |
|
| | | Cosmetic products not intended for the treatment of human ailments |
|
| | | Chinese proprietary medicines; herbal substances in raw form described in the current edition of “A Dictionary of Chinese Pharmacy” <<中药大辞典>> or “The Chinese Herbal Medicine Materia Medica” <<本草纲目>>, intended for the manufacture of Chinese proprietary medicines only |
|
| Androgenic, oestrogenic and progestational substances, the following: |
| | | Preparations intended for external application only, except preparations containing more than 4 mg of oestrogenic substance per hundred grammes of inert substances; feeding stuffs containing hexoestrol or stilboestrol or both and not containing any other androgenic, oestrogenic or progestational substance |
|
| | |
| | Derivatives of stilbene, dibenzyl or naphthalene with oestrogenic activity; their esters; their ethers; their salts |
| |
| | Steroid compounds with androgenic or oestrogenic or progestational activity; their esters; their ethers; their salts |
| |
| Antibiotics, the following, their salts; their esters: |
| | | Preparations for animal feeding containing not more than the equivalent of 5 parts of antibiotic substance in 100 parts of feeding stuff; sensitivity bio‑discs incorporated with antibiotics for laboratory use only; media containing antibiotics for storage of organs or tissues to be transplanted which are not intended for the treatment of human ailments |
|
| | |
| | 2’-amino-2’-deoxy kanamycin |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | Cephalosporins, that is to say, the antimicrobial substances containing in their chemical structure a fused dihydrothiazine β‑lactam nucleus |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | Lincomycins, that is to say, the S-alkyl derivatives of 6,8‑dideoxy-6-trans-(4‑alkyl-L-2-pyrrolidine carboxamido)-1-thio-D‑erythro-α-D‑galacto-octopyranoside, and N‑methyl-pyrrolidine analogues thereof |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | Penicillin, any antimicrobial acid, any salt thereof, or any derivative which is obtained therefrom, which may be shown on chemical and physical examination to contain in its structure a fused thiazolidine β-lactam nucleus |
| |
| | |
| | Rifamycins, that is to say, a group of related antimicrobial microlactans, either produced by the growth of Streptomyces mediterranei or by modification of such products, and containing the chemical structure of 11-acetoxy‑7,9,15-trihydroxy-13-methoxy-2,6,8,10,12-pentamethyl-pentadeca-2,4,14-trienoic acid amide, attached by the nitrogen atom and by the oxygen atom in the 15‑position respectively to the 7- and 2-positions of a 5,6,9-trioxygenated 2,4‑dimenthyl-1-oxonaphtho (2,1‑b) furan |
| |
| | |
| | |
| | |
| | Streptomycin and its derivatives |
| |
| | Tetracyclines, that is to say, the antimicrobial substances containing the chemical structure naphthacene-2-carboxymide, hydrogenated to any extent and having each of the positions 1, 3, 10, 11 and 12 substituted by a hydroxyl or an oxo group |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| Anti-histamine substances, the following; their salts, their molecular compounds: |
| | | Preparations intended for external application only and preparations containing not more than 1% of anti-histamine substances for application in the nose or eye |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | 3-Di-n-butylaminomethyl-4,5,6-trihydroxyphthalide |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | Substances being tetra‑N‑substituted derivatives of ethylenediamine or propylenediamine |
| |
| | |
| Barbituric acid; its salts; derivatives of barbituric acid; their salts; compounds of barbituric acid; their salts; their derivatives, their salts, with any other substance |
| | | Self-heating preparations, in aerosol dispensers, intended for external application only, containing 1,5-diethyl-2-thio-4,6-pyrimidinedione and not containing any other substance mentioned opposite hereto in the first column |
|
| | | External preparations containing not more than 1% of benzocaine |
|
| Berberine; its quaternary compounds; their salts |
| | | Cosmetic products not intended for the treatment of human ailments; Chinese proprietary medicines; herbal substances in raw form described in the current edition of “A Dictionary of Chinese Pharmacy” <<中药大辞典>> or “The Chinese Herbal Medicine Materia Medica” <<本草纲目>> |
|
| Boric acid; sodium borate |
| | | Medicinal preparations, cosmetics and toilet preparations containing not more than 5% boric acid, or 5% sodium borate or 5% of a combination of both; substances not being preparations intended for human consumption |
|
| | | Preparations intended for topical application only |
|
| | | Cosmetic products not intended for the treatment of human ailments |
|
| | | Substances containing less than 1% of chloroform; solid preparations; toothpaste; substances not being preparations intended for the treatment of human ailments |
|
| | | Preparations intended for dermatological uses, containing not more than 1% of clotrimazole; cosmetic products not intended for the treatment of human ailments |
|
| Creosote obtained from wood |
| | | Substances containing less than 50% of creosote obtained from wood |
|
| Deanol, except deanol aceglutamate |
| | | Cosmetic products not intended for the treatment of human ailments |
|
| Diclofenac diethylammonium |
| | | Preparations intended for external application only, and containing diclofenac diethylammonium salt equivalent to not more than 1% of diclofenac sodium |
|
| | | Preparations intended for external application only, containing not more than 1% of diperodon calculated as anhydrous base |
|
| | | Substances not being preparations for the treatment of human ailments |
|
| | | Preparations intended for dermatological uses, containing not more than 1% of econazole calculated as its free base |
|
| | | Preparations for animal feeding containing furaltadone |
|
| | | Preparations for animal feeding containing furazolidone |
|
| | | Dermatological preparations containing not more than 1% of haloprogin |
|
| | | Preparations intended for external use only |
|
| | | Substances containing not more than 0.1%, weight in weight, of hexachlorophene except preparations for infant use |
|
| Hydroxyquinoline; its salts; its derivatives; their salts |
| | | Substances not being preparations for the treatment of human ailments |
|
| | | Preparations intended for dermatological uses, containing not more than 1% of ketoconazole calculated as its free base |
|
| Lead acetate; compounds of lead with acids from fixed oils |
| | | Substances not being preparations intended for the treatment of human ailments; substances containing less than 4% of lead acetate |
|
| | | External preparations containing not more than 8% of lignocaine base |
|
| | | Substances other than those intended for treatment of human ailments |
|
| | | Substances containing less than 1% of lovastatin |
|
| | | Ointments containing less than the equivalent of 3%, weight in weight, of mercury (Hg) |
|
| | | Canker and wound paints (for trees) containing not more than 3%, weight in weight, of yellow mercuric oxide |
|
| | |
| | | Chinese proprietary medicines; herbal substances in raw form described in the current edition of “A Dictionary of Chinese Pharmacy” <<中药大辞典>> or “The Chinese Herbal Medicine Materia Medica” <<本草纲目>>, intended for the manufacture of Chinese proprietary medicines only |
|
| | | Preparations intended for dermatological uses, containing not more than 2% of miconazole calculated as its free base |
|
| Mustine and any other N‑substituted derivatives of di‑(2-chloroethyl) amine; their salts |
| | | Substances not being preparations intended for the treatment of human ailments |
|
| | | Preparations for animal feeding containing nitrofurantoin |
|
| | | Preparations for animal feeding containing nitrofurazone |
|
| m-Nitrophenol; o-Nitrophenol; p-Nitrophenol |
| | | Substances not being preparations intended for the treatment of human ailments |
|
| | | Cosmetic products not intended for the treatment of human ailments |
|
| Phenethylamine; its salts |
| | | Preparations containing not more than 300 ppm of phenethylamine |
|
| | | Preparations containing less than 1% of phenols; nasal sprays, mouth washes, pastilles, lozenges, capsules, pessaries, ointments of suppositories containing less than 2.5% of phenols; in reagent kits supplied for medical or veterinary purposes; smelling bottles; soaps for washing; solid substances, other than pastilles, lozenges, capsules, pessaries, ointments and suppositories, containing less than 60% of phenols; tar (coal or wood), crude or refined |
|
| | | Toilet, cosmetic and therapeutic preparations containing not more than 0.01% of phenyl mercuric salts as a preservative; antiseptic dressings on toothbrushes; in textiles containing not more than 0.01% of phenyl mercuric salts as a bacteriostat and fungicide |
|
| | | Substances not being preparations intended for the treatment of human ailments; substances containing less than 5% of picric acid |
|
| Piper methysticum (kava-kava), the active constituents of; kava pyrones (kavalactones); their quaternary compounds; their salts |
| | | Cosmetic products not intended for the treatment of human ailments |
|
| | | Preparations containing not more than 1.5%, weight in weight, of podophyllum resin |
|
| | | When associated with not more than 1 in 10,000 parts with penicillin in preparations for animal feeding |
|
| | | External preparations containing not more than 2.5% of selenium sulphide |
|
| Sodium ethyl mercurithiosalicylate |
| | | Therapeutic substances containing less than 0.1% of sodium ethyl mercurithiosalicylate as a preservative |
|
| | | Substances containing less than 3% of sodium fluoride as a preservative; cosmetic products not intended for the treatment of human ailments; tablets containing not more than 0.016% in weight of sodium fluoride and intended, when chewed, to prevent tooth decay; dentifrices containing not more than 0.5% of sodium fluoride; mouth wash tablets containing not more than 0.2% of sodium fluoride and liquid mouth washes containing not more than 0.05% thereof; tablets containing not more than 0.016%, weight in weight, of sodium fluoride and intended, when chewed, to prevent tooth decay |
|
| | | Substances other than preparations containing more than 0.1% of sodium nitrite for the destruction of rats and mice |
|
| | | Preparations intended for dermatological uses, containing not more than 1% of terbinafine calculated as its free base |
|
| Tetrahydropalmatine; its isomers; their salts |
| | | Chinese proprietary medicines; Corydalis yanhusuo in raw form described in the current edition of “A Dictionary of Chinese Pharmacy” <<中药大辞典>> or “The Chinese Herbal Medicine Materia Medica” <<本草纲目>>; herbal substances in raw form described in the current edition of “A Dictionary of Chinese Pharmacy” <<中药大辞典>> or “The Chinese Herbal Medicine Materia Medica” <<本草纲目>>, intended for the manufacture of Chinese proprietary medicines only |
|
| Theophylline; its salts; its derivatives; its compounds |
| | | Preparations containing 8‑bromotheophylline compound with 2‑amino-2-methyl-1-propranol (Pamabron) |
|
| | | Cosmetic products not intended for the treatment of human ailments |
|
| Thiouracil; its alkyl derivatives |
| | | Substances not being preparations intended for the treatment of human ailments |
|
| | | Preparations intended for dermatological uses, containing not more than 1% of tolnaftate |
|
| | | Preparations containing not more than 0.05% of tranexamic acid; cosmetic products not intended for the treatment of human ailments |
|
| | | Preparations for destruction of rats and mice containing not more than 0.1% of warfarin |
|
